Aspen signs R10 billion deal with MSD
Oss, Netherlands – JSE Limited listed Aspen Holdings is pleased to announce that the Aspen Group (“Aspen”), the ninth largest generic pharmaceutical company in the
Renewal of Cautionary Announcement
APN – Aspen Pharmacare Holdings Limited – Trading statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code:
Aspen to invest more than R1,9 billion in infant nutritional deal with Pfizer
Shareholders of Aspen Holdings are advised that Aspen Group companies (“Aspen”) have concluded agreements with Nestlé S.A. in respect of the acquisition of certain rights
Renewal of Cautionary Announcement
Shareholders are referred to the cautionary announcement released by Aspen on 4 February 2013 (and subsequent renewals of this cautionary announcement) in which shareholders were
Cautionary Announcement – Discussions with MSD
ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen” or “the Company”) CAUTIONARY ANNOUNCEMENT
Aspen Global acquires Australian product portfolio for R2.2 billion
The Aspen Group (“Aspen”) is pleased to announce that Aspen Global Incorporated (“Aspen Global”), a wholly owned subsidiary of Aspen Holdings, has reached agreement with
Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages
Johannesburg – over the past days and weeks, there have been widespread reports from various State Clinics, in certain provinces, that patients have been unable
30 000 ARV packs delivered in Limpopo
Following discussions between the health Minister Dr Aaron Motsoaledi and Aspen Pharmacare Senior Executive Mr Stavros Nicolaou in Johannesburg, Aspen Pharmacare released 30 000 packs
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
